- Home
- PDSB vs DERM Comparison
PDSB vs DERM Comparison
Compare PDSB & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDSB
- DERM
- Stock Information
- Founded
- PDSB 2005
- DERM 2014
- Country
- PDSB United States
- DERM United States
- Employees
- PDSB N/A
- DERM N/A
- Industry
- PDSB Biotechnology: Pharmaceutical Preparations
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- PDSB Health Care
- DERM Health Care
- Exchange
- PDSB Nasdaq
- DERM Nasdaq
- Market Cap
- PDSB 114.9M
- DERM 107.0M
- IPO Year
- PDSB N/A
- DERM 2021
- Fundamental
- Price
- PDSB $2.01
- DERM $5.16
- Analyst Decision
- PDSB Strong Buy
- DERM Strong Buy
- Analyst Count
- PDSB 3
- DERM 3
- Target Price
- PDSB $15.00
- DERM $9.50
- AVG Volume (30 Days)
- PDSB 526.2K
- DERM 158.2K
- Earning Date
- PDSB 11-14-2024
- DERM 11-12-2024
- Dividend Yield
- PDSB N/A
- DERM N/A
- EPS Growth
- PDSB N/A
- DERM N/A
- EPS
- PDSB N/A
- DERM N/A
- Revenue
- PDSB N/A
- DERM $57,771,000.00
- Revenue This Year
- PDSB N/A
- DERM N/A
- Revenue Next Year
- PDSB N/A
- DERM $37.38
- P/E Ratio
- PDSB N/A
- DERM N/A
- Revenue Growth
- PDSB N/A
- DERM N/A
- 52 Week Low
- PDSB $1.53
- DERM $2.85
- 52 Week High
- PDSB $6.74
- DERM $8.11
- Technical
- Relative Strength Index (RSI)
- PDSB 19.40
- DERM 41.77
- Support Level
- PDSB $1.53
- DERM $5.00
- Resistance Level
- PDSB $3.41
- DERM $5.82
- Average True Range (ATR)
- PDSB 0.27
- DERM 0.43
- MACD
- PDSB -0.12
- DERM -0.08
- Stochastic Oscillator
- PDSB 24.62
- DERM 11.99
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.